Partner With Us
Through extensive research with industry leaders from Pfizer, Sanofi, Bayer, BioNTech and the FDA within the LNP field, it is clear that understanding the full extent to which we can use LNP-based drugs for vaccines, gene editing, oncology applications, and payloads beyond mRNA is a great challenge, and further to that, the capacity of the service providers available to them. This is a major bottleneck, with high pressured timelines in the race to deliver safe and effective therapeutic products to patients in need.
If you are a contract service or technology provider with the analytical experience and specific technologies to meet this exploding markets’ demands, then the 2nd LNP Immunogenicity & Toxicity Summit will provide a platform for you to showcase your solutions to a niche audience of experts from the field.
Experts need your help with: